Novo Nordisk: Switch To Weekly Ozempic Has Begun, Biopharma M&A Sought

 
• By Sten Stovall
  
Diabetes
Effective launch of the once-weekly GLP-1 Ozempic is vital for the future of Novo Nordisk • Source: Shutterstock

More from Strategy

More from Business